VentriPoint Diagnostics (TSE:VPT) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Ventripoint Diagnostics has secured EU CE Mark certification for its advanced AI-powered heart-scanning technology, VMS+4.0, opening new market opportunities in Europe. The VMS+4.0 offers improved user experience by automating image processing and working seamlessly with magnet-free sensors, enhancing efficiency and accuracy in cardiac measurements.
For further insights into TSE:VPT stock, check out TipRanks’ Stock Analysis page.
